Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Rusconi

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Expert Review of Clinical Pharmacology|January 14, 2014
Tipranavir: a novel protease inhibitor for HIV therapyStefano Rusconi
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
Alovudine MedivirStefano Rusconi
Expert Opinion on Investigational Drugs|December 13, 2006
Novel inhibitors of the early steps of the HIV-1 life cyclePaola Citterio, Stefano Rusconi
Expert Review of Clinical Pharmacology|June 16, 2020
The crosstalk between antiretrovirals pharmacology and HIV drug resistanceAndrea Giacomelli, Laura Pezzati, Stefano Rusconi
Expert Opinion on Investigational Drugs|February 28, 2002
HIV-1 protease inhibitors in developmentStefano Rusconi, Simona La Seta Catamancio
The New Microbiologica|April 4, 2017
Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspectiveStefano Rusconi, Simone Marcotullio, Antonella Cingolani
Expert Review of Clinical Pharmacology|December 21, 2018
Clinical pharmacology in HIV cure research - what impact have we seen?Andrea Giacomelli, Sonia de Rose, Stefano Rusconi
The Enzymes|November 14, 2025
HIV protease and its inhibitionStefano Rusconi, Niccolò Paoletti, Claudiu T Supuran
Current Topics in Medicinal Chemistry|July 14, 2007
An update in the development of HIV entry inhibitorsStefano Rusconi, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Current Drug Targets. Infectious Disorders|December 8, 2004
New advances in HIV entry inhibitors developmentStefano Rusconi, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Expert Review of Clinical Pharmacology|January 14, 2014
Tipranavir: a novel protease inhibitor for HIV therapyStefano Rusconi
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
Alovudine MedivirStefano Rusconi
Expert Opinion on Investigational Drugs|December 13, 2006
Novel inhibitors of the early steps of the HIV-1 life cyclePaola Citterio, Stefano Rusconi
Expert Review of Clinical Pharmacology|June 16, 2020
The crosstalk between antiretrovirals pharmacology and HIV drug resistanceAndrea Giacomelli, Laura Pezzati, Stefano Rusconi
Expert Opinion on Investigational Drugs|February 28, 2002
HIV-1 protease inhibitors in developmentStefano Rusconi, Simona La Seta Catamancio
The New Microbiologica|April 4, 2017
Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspectiveStefano Rusconi, Simone Marcotullio, Antonella Cingolani
Expert Review of Clinical Pharmacology|December 21, 2018
Clinical pharmacology in HIV cure research - what impact have we seen?Andrea Giacomelli, Sonia de Rose, Stefano Rusconi
The Enzymes|November 14, 2025
HIV protease and its inhibitionStefano Rusconi, Niccolò Paoletti, Claudiu T Supuran
Current Topics in Medicinal Chemistry|July 14, 2007
An update in the development of HIV entry inhibitorsStefano Rusconi, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Current Drug Targets. Infectious Disorders|December 8, 2004
New advances in HIV entry inhibitors developmentStefano Rusconi, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Pageof 20